A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved SumavelTM DoseProTM -- Novel Product Recently Approved by the FDA for Treatment of Acute Migraine and Cluster Headache --
Aug 3, 2009